{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:56:34Z","timestamp":1778176594773,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jogoh.2020.101944","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T13:25:48Z","timestamp":1602768348000},"page":"101944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does type of cancer affect ovarian response in oncofertility patients?"],"prefix":"10.1016","volume":"50","author":[{"given":"Reda S.","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaraq","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2020.101944_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2011.01.025","article-title":"Fertility preserving options in patients with gynecologic malignancies","volume":"205","author":"Eskander","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0010","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jogoh.2020.101944_bib0020","series-title":"Mayo Clinic Proceedings","first-page":"770","article-title":"Fertility preservation in women: indications and options for therapy","author":"Hussein","year":"2020"},{"issue":"3","key":"10.1016\/j.jogoh.2020.101944_bib0025","article-title":"Fertility preservation in female cancer patients: an overview","volume":"8","author":"Mahajan","year":"2015","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.jogoh.2020.101944_bib0030","series-title":"Recent data from the national vital statistics system","article-title":"Are preterm births on the decline in the United States?","author":"Martin","year":"2010"},{"issue":"122","key":"10.1016\/j.jogoh.2020.101944_bib0035","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/cncr.29953","article-title":"Preliminary estimates of SEER cancer incidence for 2013","author":"Lewis","year":"2016","journal-title":"Cancer"},{"issue":"2500","key":"10.1016\/j.jogoh.2020.101944_bib0040","article-title":"Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.05.034","article-title":"Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion","volume":"110","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.fertnstert.2013.08.041","article-title":"Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion","volume":"100","author":"Ethics Committee of the American Society for Reproductive Medicine","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0055","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2012.09.003","article-title":"Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis","volume":"99","author":"Roque","year":"2013","journal-title":"Fertil Steril"},{"issue":"107","key":"10.1016\/j.jogoh.2020.101944_bib0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fertnstert.2016.10.002","article-title":"Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013","author":"Crawford","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","article-title":"Ovarian stimulation for fertility preservation in patients with cancer","volume":"93","author":"Quintero","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0075","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fertnstert.2012.01.093","article-title":"Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment","volume":"97","author":"Domingo","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","article-title":"Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis","volume":"97","author":"Friedler","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0085","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/13.7.1837","article-title":"Malignancy may adversely influence the quality and behaviour of oocytes","volume":"13","author":"Pal","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101944_bib0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.fertnstert.2012.05.010","article-title":"Effects of malignancies on the gonadal function","volume":"98","author":"Tulandi","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2010.04.028","article-title":"Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy","volume":"95","author":"Robertson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fertnstert.2011.04.070","article-title":"Ovarian reserve, response to gonadotropins, and oocyte maturity in women with malignancy","volume":"96","author":"Das","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10815-014-0183-6","article-title":"Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram","volume":"31","author":"Devesa","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2020.101944_bib0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10815-015-0428-z","article-title":"Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience","volume":"32","author":"Cardozo","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2020.101944_bib0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/COC.0000000000000031","article-title":"Fertility preservation decisions among newly diagnosed oncology patients: a single-center experience","volume":"39","author":"Nurudeen","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0120","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.fertnstert.2005.07.169","article-title":"Fertility preservation in female cancer patients","volume":"84","author":"Quintero","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.fertnstert.2008.07.1727","article-title":"Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins","volume":"91","author":"Knopman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fertnstert.2009.03.028","article-title":"Fertility preservation for female cancer patients: early clinical experience","volume":"94","author":"Klock","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0135","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","article-title":"Five years\u2019 experience using oocyte vitrification to preserve fertility for medical and nonmedical indications","volume":"99","author":"Garcia-Velasco","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and Breast\/Ovarian Cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"issue":"111","key":"10.1016\/j.jogoh.2020.101944_bib0145","article-title":"Fertility preservation outcomes may differ by cancer diagnosis","volume":"7","author":"Pavone","year":"2014","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.jogoh.2020.101944_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.rbmo.2018.04.047","article-title":"Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type","volume":"37","author":"Lefebvre","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogoh.2020.101944_bib0155","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogoh.2020.101944_bib0160","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","article-title":"Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience","volume":"31","author":"Reddy","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.jogoh.2020.101944_bib0165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.fertnstert.2017.06.027","article-title":"Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation","volume":"108","author":"Pereira","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0170","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0175","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.fertnstert.2014.07.118","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropin in patients with breast cancer: a prospective controlled study with subgroup analysis","volume":"102","author":"Kim","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2020.101944_bib0180","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1093\/humrep\/dey321","article-title":"Elective and Onco-fertility preservation: factors related to IVF outcomes","volume":"33","author":"Cobo","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogoh.2020.101944_bib0185","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2020.101944_bib0190","article-title":"Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients","volume":"4","author":"Sonigo","year":"2019","journal-title":"Eur J Obstetr Gynecol Reprode Biol: X"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784720303081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:58:17Z","timestamp":1762855097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784720303081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2468784720303081"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101944","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does type of cancer affect ovarian response in oncofertility patients?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101944"}}